 |
 | Multiple Storage Requirements |  | Dry ice |  | Multiple Toxicity Values, refer to MSDS | | Note: Store and Ship conditions may differ. | | See Key |
|
 |
 |
 |
| | InnoZyme™ TACE Activity Kit | |  | Cat. No. CBA042 | |
a-Secretase Activity Kit ADAM17 Activity Kit TNF-a Converting Enzyme Activity Kit | Format: 96-well plate | | Form: 96 Tests | | Detection Method: Fluorometric | | Assay Range: 5-100 ng/ml as measured with purified recombinant human TACE | | Sample Type: Cells | | Positive Control: Human recombinant TACE | | Kit Contents: Anti-Human TACE-Coated 96-Well Plate, Control, Substrate, Sample Buffer, Assay Buffer, Wash Buffer, Plate Sealer, and a user protocol. | | Comments: The InnoZyme™ TACE Activity Kit is a specific and sensitive assay designed to measure human TACE activity in cell lysates and biological samples and for screening enzyme inhibitors. An Anti-Human TACE-Coated 96-Well Plate is pre-coated with a monoclonal antibody specific for human TACE that captures the enzyme. Unbound material is discarded, the plate is washed, and the activity of captured TACE is measured using an internally quenched fluorescent substrate, MCA-KPLGL-Dpa-AR-NH2. Cleavage of the scissile amide bond, G-L, releases the fluorophore from the quenching molecule, Dpa, resulting in an increase in fluorescence. Fluorescence of the cleaved product, MCA-KPLG, is measured at an excitation wavelength of ~324 nm and emission wavelength of ~400 nm. The level of fluorescence is directly related to the enzyme activity. | | Ref.: Kirkegaard, T., et al. 2004. Clin. Exp. Immunol. 135, 146. Neumann, U., et al. 2004. Anal. Biochem. 328, 166. Skovronsky, D.M., et al. 2001. J. Neurobiol. 49, 40. Black, R.A., et al. 1997. Nature 385, 729. Moss, M.L., et al. 1997. Nature 385, 733. | | Not available for sale in Germany. | |
| Related information for this product is available: | |
| |
EMD Chemicals Inc. list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.
 Activity of Recombinant Human TACE. The activity of increasing concentrations human recombinant TACE (Cat. No. PF133) was measured according to the Detailed Protocol above.
 Activity of TACE/ADAM17 in Biological Samples. Human colorectal adenocarcinoma cells, DLD1 and HT-29 and human glioblastoma cells, T98G, were cultured in DMEM medium supplemented with 10% FCS and harvested at 80-90% confluency. Total cell lysates were prepared using CytoBuster™ Protein Extraction Reagent (Cat. No. 71009) and the manufacturer's recommended protocol. TACE activity was measured according to the Detailed Protocol above. RFU is reported per mg protein.
|
|
|